BBOT
NASDAQ · Biotechnology
Bridgebio Oncology Therapeut
$7.89
+0.03 (+0.38%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+446.3% upside
Low Target
$22.76
Average Target
$43.10
High Target
$48.38
Current Price
$7.89
Current
$7.89
$7.89
Target
$43.10
$43.10
$22.76
$43.10 avg
$48.38
Scenario Analysis
Bear Case
$22.76
188.5%
Low target
Base Case
$43.10
+446.3%
Avg target
Bull Case
$48.38
+513.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$14.87
-46.9% from high
52-Week Low
$7.60
+3.8% from low
Target vs 52W High
$43.10
+189.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |